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Ohjediw. The aim of this study was to test the hypothesis that 
diiilalis elycosids would reduce sympathetic activity as reAecled 
by forarm veooos norepinephrine kinetic% in patients with con. 
gestive heart failure. 
Bnck~ground. Di@alb glycmides have b-en reported to de- 
cream sympathetic nerww system activity with baroreceptor 
Sensitization in experimental animals. Such effects would b of 
therawutic immxtance in canewtive keart failure. 
Mkhods. &uble-bliod randomized assessment was made of 
the e8eets of tow dose intravenous dertanmide Keditanid-D, 
0.002 mpikg bdy weigh,, and vehicle on hem-t rate, arteria, 
pressure, forearm hlwd Row, plasma norepinephrine, norepi- 
nmhrine clearance and norminemxine xdllover in nine mtients 
wiih stable congestive heart fail&z. New-York Heart As&&n 
functional class II or 111. Open I&! wcssment of the rwwoses to 
0.6 mg of derbmaside war kade in an overlapping grou~of seven 
paiientr. A,, measurementi were made 30 and 60 min after 
intravenous btjectior- of drug or vehicle and tier 15 min of 30’ 
Apart from its direct ino!ropic and vasoconsirictor actions. 
digitalis may influence the circulation through central sym- 
pathostimulation and sensitization of cardiopulmonary and 
sinomxtic baroreceptors with vagal afferent fibers (l-6). Net 
sympathetic withdrawal in response to a variety of barore- 
ceptor-related stimuli in experimental animals is enhanced 
by short-term digitalization (2.6). These observations have 
led to speculation that a potential explanationfoisomeofthe 
beneficial effects of digitalis in congestive heart feilurc could 
be a reduction in sympathetic tone if digitalis acted to 
pariiaiiy restore depressed haroreceptar sensitivity. Fergu- 
son et al. (7) recently reported that the short-term adminis- 
tration of a pressor dose of deslanoside (Cedilanid-D) re- 
bead-dawn Lilt as at& of the sympnthadc response to barnrecap 
tar loading. 
Resrdls. Heart rate. arteriltl rxessure and forearm bled Row 
were uncbqed by I& dose d&anorlde. Heart rate dEa’eased 
digbUy with the 0.6 mg dme with Lhe ptiientr in the supine 
position. Norepinrphrine spitlover and clearance decreased with 
time cm each study day in the supine position, but no effect was 
attributable to digitalis. Plasma norepiapbrine and nwepineph- 
vine clearance and spiltover aU remained unchanged during 
head.down tilt on each smdy day. 
Conclusions. N~m,resmr doses of deslnnoside do no, smmrem 
symp,hetie aetitity .as rellff(ed by vemms norepinophri~ and 
norepinephrine spillover in patients wilh cmtgeotive heart Mhtre. 
Further, derlamnidr did mot normalize the sympatheiic rqm~se 
to mild barnreceptor toad@ produced by hmd.down tilt. Ihme 
datp do not support sympatboiohibiti@n through barorwxptor 
wnsi,imtion as a Likely e&t of diiitnlii in coagmtivr bemt 
failure. 
(J Am Co/l Cardiol1992:20:658-63) 
duced sympathetic nerve activity in a peripheral muscle bed 
in patients with severe congestive heart failure. In that study 
the attriburion of the response to digitalis rather than to 
barnreceptor activation itself was complicated by an in- 
crease in systolic prcssorc after administration of the drug, 
without an appropriate pressor control. In the current study, 
we investigated the possibility that nonpressor doses of 
digitalis would decrease basal systemic venous norepineph- 
rine spillover. a more global if less direct assessment of 
sympathetic activity than that of recordings from a single 
neur~vascular bed. As a further exploration ofthe possibility 
that digitalis sensitizes baroreceptors in congestive heart 
failure. we also examined whether digitalis would nornaliz; 
the previously reported failure of mild barorcceptor loading 
mancwers to suppress increased sympathetic activity in 
chronic congestive heart failure (8.9). We conducted there 
studies in patients in stable condition with moderate conga- 
tive heart failure zid used a vehicle-costrolled. double-blind 
design for a low dose of digitalis and an open l&l design for 
a single-day study of a larger dose. The results are not 
consistent with a major inhibitory effect of short-term digi- 
talis use on systemic sympathetic nerwus system activity in 
congestive hean faitwc. either in the supine position or 
doting mi!d baroreccptor loading produced by hex-down 
lilt. 
failure participated~n the initial qttidiss. Eight&e malt and 
the aae ranged from 34 lo 17 wan (mean 57). Th: ctioloev of 
cong&tiveheart failure included ischemic cardiomywathy 
in live patients and idiopathic dilated cardiomyop&!hy in 
four. By echocardiography, all patients had documented. 
moderatelv severe to severe reductions in left ventriculst 
systolic function. In ocr laboratory, these ~ssessmems 
reliably predict an ejection fraction 435%. All patients were 
in clinically stable condition at the time of study. Three 
were in New York Heat? Association functional class II and 
six in functional class Iii. Medications included d&tic 
drugs in all cases and angiotcnsin-converting enzyme mhib- 
itors in seven of the nine. Three patients were receiving 
maintenance digitalis therapy. In these patients, digitalis was 
withheld at least 1 days before the study. The other six 
patients had had no digitalis therapy. Diuretics and angioten- 
sin-convertinp, enzyme inhibitors were not eiven before the 
investigation& study days: therefore, theiasl doses were 
given I2 to 24 h before study. 
A second study grottp included six of the original patients 
plus one additional 57.year old male patient with ischemic 
cardiomyopathy in functional class II. He had had no 
treatmeat with digitalis. Preparation for the second study 
group was identical o tha’ for the first study group. 
Pmtwd. Fc the original study, patients reported to an 
oatpatient procedure laboratory. were positioned on a IP 
bed and had intravenous cannulas placed in each arm. 
Temperattx in toe room was constant and at 70°F. Thirty 
minutes of supine rest was allowed after the cannulas were 
placed. Heart rate (from an electrocardiographic IECGI 
lead) sad mean atrerial pressare (from an automated sphyg- 
momanometric device) were then recorded, and a plasma 
blank was obtained lo, li!er use in the norepinephrine 
kinetic measurements. An infusion of ttitiated aorepineph- 
rine (‘HNE, Dtqxmt-New Enaland Nuclear) was then 
staned with a 12 pCi bolos and a steady state infusion rate of 
0.8 Cilmin. This rate was maintained for M) min with heart 
t-ate, blood presswe, forearm blood Row (obtained by mer- 
cary-in-Silastic strain gauge cuff plet!wnography), plasma 
norepinepbrine aad plasma ‘HNE all measured at 50 and 
60 min. After the 6Omin mearuremcnts. an infusion of either 
deslanoside (Cedilanid-D) (OaO2 menig body weigh,) or 
vehicle (5% dextrose in water) wm a&n over 5 min. All 
vatiab!es were reassessed 30 and 60 min after the infusion of 
deskmoside or vehicle. At M) mitt, the patients were placed 
into a 30” head-down tilt with all variables assessed a final 
time after IS mitt in this position. 
All patier% were studied on two occasions al least I week 
apart. Deslattoskle and vehicle were given ia doubl,bliod 
manner nod the order of adminislration was sodomized. 
iLr Gw wonrl &Jy, the identical procedures were 
followed except that 0.6 mg of derlanoside was given on an 
open !a&! basis oa ! day on!y. Forearm blood Row was not 
measured in rite second study. 
FlaEma twrptrept~rils ktnriifs. Norepinephrine kinetics 
were assessed by the method of E3er et at. (ID) using a 
steady state infusion of I-17~3H]-narepineph~ine in trace 
zmoumr. At steady state. if endogen osos eoreiiv;piids? and 
infused. radiolabeled norepinephrine are cleared at equiva- 
lent rates, and there is no recirculation of tracer in the body, 
then: 
NE “spiltover” 
-- 
Plasma [WE] (p&l) 
,t”f”rion &xc ‘I-WE) tm”mi”, [‘HNE inf”stc] @Jpmfmt, 
S 
F?asma [‘HNE] (dpmfliter) 
Knowingtheiofosionratefor’HNE. theconcentmtionof 
infused ‘HNE. the plasma concentration of ‘HNE and the 
concentratton of endogenous plasma norepinephrine. one 
can then calculate the spitlover ra!c of cndogenous norepi- 
nepbtine (NE): 
= Plasma NE (pgiml) x Clearance ‘HNE Uiterslmin). 
This techaique has now been applied extensively in both 
animal and human inveaigatioas, and given the assumptions 
staled, it is accepted as a m-casttre of the kinetics of norep 
inephrine under steady state conditions. The key advantage 
of the method is that one can make inferences about aot’epi- 
nephtine release aad not rely solely on plasma norepi- 
nephrine concentration, which is tiected independently by 
both release rates and clearance. However, spil!over is s!ill 
30 indirect reflection of sympathetic nervous system activity 
because it measures only the release of ttorepiwphriw into 
the bloodstream, and not direct synaptic cleft norepineph- 
tine concentrations or nerve IraEic. This method is clearly 
more attractive than relying solely oo plasma norcpinephriw 
assc~smcm and has the additional advantage over locrdized 
net-x tw&ic ECOdingS of asses.&! the integrated activity of 
the sympathetic nervow system. 
Assays. Blood samples from the assays were kept on :ce, 
centrifuged at 4°C immediately after the study aad frozen at 
-70°C until assay. Plasma norepinephrine was measured by 
mdioenzymatic methodswith the Cat-a-Kit (Amenham Cor- 
poration). Concentmtions of ‘HNE (dpm/ml) were me-red 
by adsovtion of plasma catecholamines onto acid-w&d 
alumina, elution with 0.2 N hydrochloric acid and direct 
scirG&on counting of ihe eiuates. It&ion rates were 
calculated from the activity of lritiatcd narepinephtine in 
the infusate and the volume rate of infusion. Ml sxnpks 
from an individual subject were assayed in duplicate in the 
same assay. In this group of subjects, the recovery of 
tritmted nonpinephrine added to plasma in the concentr~ 
TsMe 1. Hemodynamic Responses Ourirg Vehicle and 
Destanoridr Adminisrration 
tion range produced by the experiment was 78 k 8%. 
Variation between duplicate samples in the same assay 
averaged 3%, and the interassay variation for duplicate 
sx1ples was ‘8%. 
St&tics. The hypotbwzs teaied were whether ij ridler 
dose of deslanoside aLcted any variable measured in the 
supine position, compared with vehicle control, and 
2) whether the responses to head-down tilt were different 
after either dose of deslanoside than after vehicle control. 
Statistical analyses included 1) multiple factor analysis of 
variance (ANOVA) for within-day and between-day data on 
the original blinded, controlled study; 2) one-way ANOVA 
for repeated measures on the data collected from the higher 
dose study; 3) repeated measores ANOVA on the abmlote 
changes fmm control valoes and the responses to head-down 
tilt for the six subjects studied with both doses of drug as 
we!1 as with vehicle control; and 4) factorial ANOVA for the 
absolute chzngees from control values and the responses to 
tilt for all data, that is, comparing changes on the vehiik day 
with both doses ofdrug and corr.paring the results after each 
dose with the other. p values < 0.05 were accepted as 
significant. 
Results 
Table I contains the data for heart rate, arterial pressure. 
forearm blood flow and forearm vascular resistance from al1 
Figure 1. Meanvalues t SEM fornorepinephrine(NE) IromfJJmin 
after initiation ofthe tritiated norepinephrtne infusion ControlL 30 
and 60 min after vehicle (blab bars). tow dose (0.W2 mgikg. hat&d 
bars) and moderate dose CO.6 mg. gay bars) derlanoside and during 
head-down tilt. Analysis of variance for the changes between 
control and 30 rein, centrot and 60 min end 60 min and Lit! rcvcatcd 
no differences among vehicle and low and moderate dose deslano- 
side. 
three study days. The only significant change either between 
or within days was a small decrease in heart rate after 
administration of 0.6 tog of deslanoside. 
Figures I to 3 contain the results of plasma norepineph- 
rine, norepinephrine clearance and narepinephtine spillover 
measurements from the total study group. Values from 50 
and 60 min after initiating 3HNE infusions were not differen!; 
Figare 2. Mean wlues 2 t SEM for norepinephrine INEt etrsmnw 
from M) mm after initiation ot the totrated norepmephrine infusion 
Control). 30 and 60 rein aiter vehicle (black bars), low dor 
tO.MI2 m&g, hatched hers) and modera!e dose to.6 mg, gray bars) 
deslanoside and during had-down tilt. Analysis of variance for the 
changes between control and 30 min, control and MI win and 60 rein 
and tilt values revealed no differences among vehicle. and low and 
moderate date des!anoside. 
the 6O.min values are included on the graphi as control 
values 
Plasma mreplnephrine (Fig. 1). This value was not dif- 
ferent zt control on the 3 study days; there was a slight 
decrease after0.6 mgafdeslanoride at 30 min (629 ? I% “MI 
546 f 165 pg/ml. p 4 0.05) demonstrated by witbin-day 
ANOVA. Factorial ANOVA for this change did not demon- 
strate significance @ = 0.19) compared with sither the 
vehicle or low dose responses. Repeated measwes ANOVA 
for ile six subjects studied on all 3 days continned the 
analyrir from the factorial ANOVA (p = U.17). No change in 
norepinephrine during head-down till occarred on any ofthe 
3 study days or between days. 
Noreplnephrlne cleanmec (I$. 2). This value was nearly 
identical at all time points on each day. There was a 
statistically significant reduction in clearance on each day 
(1.6 z 0.24 to 1.3 f 0.42 litez’tia with vehich, 1.6 2 0.44 
to 1.2 f 0.4t liters’min with low dose derknoside mod 1.6 2 
0.M to 1.2 c 0.4i literslmin with 5.6 mg deslanoside. 
Dbticasly no diierences in the between-day changes oc- 
curred either for the group as a whole or for the six subjects 
studied on each day. There was no additional effect of 
head-down tilt. 
Norep@&& spillover (Fig. 3). This value was not 
dierent in the control period on the 3 study days. Wi!hio- 
day ANOVA did indicate signifzant reductions in norepi- 
ne~xitw willow at 30 and 60 min after low dose deslaw 
side(948+ 635 to792 k 52Oand711 + 4iSug!min. p<O.O5) 
and 0.6 mg of deslanoside (I.049 * 748 to 790 i 4Fd and 
716 z 458 nglmin, p C 0.05). Kowever, it also tended to 
decrease at least at 60 mio (862 5 499 to 742 + 526 nglmin) 
on the vehicle day as well. so that neither the repeated 
measures ANOVAfortheehanges from the control value for 
the SI.X wbiects studied on three occasions nor the factorial 
ANOVA performed on all data revealed significant differ- 
ences for either control versus 30.min changes (p = 0.17 
both ANOVAs) or for conuul verses 6Omin changes (p = 
0.28 and 0.18. respectively) Neither within-day nor be- 
tween-day analyses revealed any changes in norepineptuine 
+llover dunng head-dawn tilt. 
Diiwion 
Mechanbm of dl &l&s ia umgeslive kart f&we. 
Digitalis glycosides have ken shown to exert significant 
indirect circulatory effects in a variety of experimental 
settings. Sympathoinhibitory etkts are due to the ability of 
there compounds to sensitize cardiopulmonary and sinoaor- 
tic baroreceptors (l-4.6). The mechanism is probably a 
result of the blocking e5ect of digitalis on the sodium pump 
in cellular membranes, which lowers the threshed for re- 
ceptordischarge (II ,121. The result is an enhancement oftbe 
sympathoinhibitory e5ects of the bamret?ex in response to 
baroreceptor stimulation by either chemical w mechanical 
means in the piesaxe ofdigitalis (2.6). Conversely, acentral 
sympathoexcitatory effect ofdigitalis has been demonstrated 
experimentally (51. A recen: study (13) also suggests that 
digitalis may release nwepinephriwe fmm nerve termimds, 
although a very complex promcol in anesthetized animals 
was required for the demonstration. Tk final kmodynemic 
e&c: uidigitak admini~tmtion is therefore tit+ result of the 
integration of direct inotmpic and va.soconstrictor e- 
spoanses. tbe bamretlex respwre to these effects @he ma& 
nitude of which may be increased by the drug), centm! 
sympathos:imulatory effects and possibly ttorepkpbri. 
release. In congestive heart failure, one m&ht powlate tLt 
the net beneficial effect of digitalis would imply a prepomkr- 
awe oi the positive inotmpic e5eets cowl& with ?.ym- 
patboinbibition. The torrent study, although cot directly 
measuring central hemodynamics, was designed first to test 
the hypothesis that digitalis would reduce bad sympathetic 
activity in congestive heart failure a ret&ted by petipiterai 
venous norepinephdne spillover. If present, syn&alhoinY 
bitian would be due to either bamretkx aciiuation in re. 
sponse to the inotmpic effects of the drug or enhamd 
haromtlex fottctioo if an important sensitizing e5ect of 
digitalis on bamnerptors were to occuc 
If baareceptor sensitization were the mechanism, one 
might pasttdate that the sympathetic response to further 
loadis: of banreceptors would be enhanced in the presence 
of digitalis. This hypothesis was the basis for the original 
demonstration of such e5ects by Themes and colleagues 
(2.6). To test ior it we also measured oorepineptuiw spil:- 
over during head-dawn tilt in these patients. Headdowo tilt 
inc~ases cential velwwls pressure and cardiac volumes in 
both normal subjects and patients with mogestlve heart 
failure (14.15). It also places a mild gwitational slress on 
the carotid sinus barnreceptor. Head-down lilt is thus a tid 
generalized hamreceptor lending maneuver, to which nor- 
mai subiects respond readily with a consistent decrease in 
plasma- norepinephrine and norepinephrine spillover 
another group of patients demonstrated no effect on nerve 
traffic; however, despite comparable cardiac output changes 
(8,9,16). In ~ontrest, plasma norepinephtine and norepineph- with dobutamine, no increase in systolic pressure or widen- 
rlne spillover fail to decrease during head-down tilt in ing of the pulse pressure wes seen. Therefore, the dose of 
patients with cougestive heart failure (E,Y,!S). We therefore deslanoside siren in that study may have simply activated, 
believed that if digitalis were to reduce sympathetic activity rather than sensitized. bamrefltxes. Because no specific test 
through baroreceptor sensitization in congestive heart fatl- of baroreflex function was incorporated, the results of that 
ure, there might be a normalization, or at least an improve- study are inconclusive regarding any specific effect of digi- 
meut, in the sympathetic response to head-down tilt. talis on baroreflex functien. Given the very large dose. 
The result of these studies are not consistent with an equivalent to a complete digitalizing dose of dipoxin in 5 min. 
important etTect of digitalis on sympathetic activity in pa- tee clinical relevance of the data might also be questionable. 
tients with congestive heart failure either in the supine Conversely, it might be argued that the doses we used were 
position or during head-down tilt. Neither low nor moderate simply too low to obtain an effect. However, experimental 
doses of intravenous deslanoside suppressed peripheral evidence suggests that baroreceptor sensitization is most 
venous norepinephrine spillover measured in an antecubital easily demonstrated with very low doses of digitalis prepa- 
vein in a group of patients with this syndrome who were rations (18) in large part because low doses woid some of the 
moderately ill and in stable condition. Inspection of individ- problems inherent in separating the e&t of baroreceptor 
ual day data may suggest a trend toward a reduction in activation itself from that of hamreceptor sensitization. 
spillover in the supine position after the 0.6 tug dose, but There was an autonomic effect of the 0.6 mg dose: however, 
comparison of the changes after either or both doses with as heart rate decreased, we can conclude that after nonpres- 
contml values revealed no effects attributable to drun ad- 
ministration. Dcslanoside also had no effect on the resp&es 
sor but autonomically active doses of digitalis, a decrease in 
systemic sympathetic activity is not seen. in our view, the 
of norcpinephrine or oorepinephrine spillover to head-down issue of whether a pressor dose of digitalis has sympathoin- 
tilt. As previously shown (8,9,15) in congestive heart failure, hibitory effects beyond simple baroreceptor activation is 
these responses remained impaired. ghould digitalis have unresolved. Providing !he appropriate controls to demon- 
been affecting sympathetic activity through baroreflex sen- strate such effects would be extremely difficult in heart 
sitization, effects should have been most evident during this failure given the need to balance inotmpic and pressor 
maneuver. Their absence, even on within-day analysis, effects as well as the impact of such chawes on cardiac 
diminishes the chances of a type II or beta error in the volume and pressure. 
observations made in the supine position after drug admin- Limitations of study. We used norepinephrine kinetics as 
istretion. Taken together, these results suggest that if digi- a measure of sympathetic activity in this study. Norepineph- 
talis is capable of sensitizing beroreceptors in patients with rine spillover measures released nnrepinephrlne, not nerve 
congestive heart failure, the effect is insufficient to overcome activity. A decreas: in either systemic or regional syntpa- 
the ahnorntalities in baroreflex function that characterize thetic activity could theoretically have o+xurmd and not 
this syndrome. been evident in norephtephrine spiIlover. However, ht other 
Comparison with previous studies. These conclusions studies (l9,20), changes in both plasma norephtephrlne and 
vary from previous inferences drawn by Ferguson et al. (17) 
that digitalis glycosides sensitize baroreceptors in congestive 
norepinephrine spillover have been shown to correlate with 
muscle sympathetic nerve activity recordings during 
heart failure. Their conclusions were based on observations baroregen-induced autonomic changes in normal subjects. 
that digitalis normalized the heroreflex response to lower Norepinephrine spillover changes readily in directionahy 
hody negative pressure (17) and also decreased muscle expected ways during baroreceptor loading and unloadiig in 
sympathetic activity in patients with this syndrome (7). The 
lower body negative pressure study found that digitaiis 
normal humans (9.16). Previous work from our laboratory 
(9) has also shown a preserved ability to increase ttorepi- 
converted paradoxic foreartn vasodilation to appropriate nephrine spillover during upright tilt in treated patients with 
vasoco.ts*?-rinn durina baroreceaor unloadina (17). Unfor- 
tunately, berause dig&dir has direct vasoco&ri~tin~ ef- 
congestive heart failure. Thus, in a general sense, it is likely 
fects, the relevance of that study to baroreceptor function is 
that we would have detected sympathoinhibition by digitalis 
limired without a nondigitalis vasoconstrirtor control and 
if it occurred and that only an offsetting effect of digitalis on 
release of neurotransmitter would have obscured this itthi- 
also without a direct measure of sympathetic a.%‘::y. 
In their recent study, Fergason et al. (7) eported a 
bition. Although such effects we receotIy demonstrated in 
perfused guinea pig hearts (I?.), it is unknown whether they 
reduction in muscle sympathetic new activity after admin- 
istration of deslanostde dt a dose of 0.02 mdkg given over 
occur in intact animals or humsns. If they are present, the 
clinical relevance of decreased nerve activity alter diahahs 
5 min. This dose significantly increased systolic pressure and 
widened pulse pressure. Unfortunately, there were no can. 
would then be questionable because the net-e&t o,,. 
pathetic activity as shown by neurottattsmhter levels is 
trols for these etTectects or for time and the conditions of the neutral. 
experiment. Hemodynamic controls with dobutamine in In our study, we used antecubital venous ttorepinephrine 
kinetics. Compared with arterial kinerics, peripheral venous 
kinetics give a less purely integrated measure of systermc 
synrpa,he,L. activity berwse they mclude both the equili- 
brated total mixed ~001 of norepinephrine and radialabelco 
norepinephrine, ar well a~ the eliluen, from the bed distal lo 
the sampling site, in this case the forearm. However. the use 
of antecubital venous norepinephnne ktoericr hai been 
shown to be even more sensitive to small changes in bar& 
receptor-mediated sympathetic activity in normal individuals 
than are mterial kinetics (21). This e?efcct presumably NCU~C 
because smsll banreceptor-mediated effects in the periphery 
are seen largely in the muscle beds. and these changes may not 
he reflected in atedal kinetics because small increases in 
norepinephrine from the periphery may be cleared by the lung. 
Therefore. al.iough norepinephrine kinetics are an mdirer, 
method of assessing sympathetic nervws system activity, 
venous kinetics in particular have been shavn to be very 
sensitive to small changes in the sort of ixxoreceptor-mediated 
changes in sympathetic actiwty that we were investigating. 
Finally, our patients bad compensated congestwe hear, 
failure and were takmg medications including angiotensin- 
convening enzyme inhibitors in most cases. Ihe sympa- 
thetic responses to digitalis in sicker or untreated patients 
migb, be different. However, plasma norepinephhne and 
norepinephrine spillover were both increased and the 
baroreflex responses to head-down tilt remained abnormal in
thcsc subjects despite ,reatmco,, so !here was cenainly 
opportunity to demonstrate a reduction in sympathetic & 
ti&y. particularly by agents whose mechanism is presumed 
to be baroreceptor sensitization. 
Caaelnsians. We were not able to demonstrate significant 
suppressive effects of nonpressor doses of digitalis com- 
pounds on norepinephrine or norepinephrine apillow in 
patients with heart failure, either in the supine position or 
during a baroreceptor-loading stimulus. Given the diEa- 
ences between these data and those reported by Ferguson et 
al. (7,17), we believe that it is at best an unsettled question 
whether specific and clinically important bar&reflex- 
mediated sympathetic suppression from digitalis !&aides 
might contribute to the therapeutic effects d-there agerts in 
this syndrome. 
